{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:36:13Z","timestamp":1761093373714,"version":"build-2065373602"},"reference-count":28,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2012,1,16]],"date-time":"2012-01-16T00:00:00Z","timestamp":1326672000000},"content-version":"vor","delay-in-days":2571,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2005,1]]},"abstract":"<jats:p><jats:bold>Study Objective.<\/jats:bold> To determine the influence of blood culture and susceptibility results and antimicrobial allergy history on fluoroquinolone use in the treatment of community\u2010acquired pneumonia.<\/jats:p><jats:p><jats:bold>Design.<\/jats:bold> Retrospective analysis of medical records.<\/jats:p><jats:p><jats:bold>Setting.<\/jats:bold> Centers for Medicare and Medicaid Services, Seattle, Washington.<\/jats:p><jats:p><jats:bold>Patients.<\/jats:bold> A total of 10,275 Medicare beneficiaries hospitalized with the diagnosis of pneumonia received antimicrobial treatment within 24 hours of admission. Of these patients, 288 had blood cultures positive for pneumococcus and were matched one\u2010to\u2010one with patients with negative blood and sputum cultures.<\/jats:p><jats:p><jats:bold>Measurements and Main Results.<\/jats:bold> Antimicrobial use at the beginning and end of hospitalization, culture and susceptibility results, and patient allergies were recorded retrospectively and compared between two matched groups: patients with blood cultures positive for <jats:italic>Streptococcus pneumoniae<\/jats:italic> and those whose blood and sputum cultures were negative. Neither culture and susceptibility results nor allergy history affected the rate of fluoroquinolone use. Despite infection due to penicillin\u2010susceptible pneumococci and no penicillin allergy, patients received therapy with fluoroquinolones (26.7%) as frequently as those with culture\u2010negative pneumonia (34.9%; p=0.401).<\/jats:p><jats:p><jats:bold>Conclusion.<\/jats:bold> Fluoroquinolones are prescribed despite microbiologic confirmation of penicillin\u2010susceptible pneumococcal pneumonia in the absence of penicillin allergy. These prescribing patterns may contribute to selection pressure associated with fluoroquinolone\u2010resistant gram\u2010positive and gram\u2010negative bacteria.<\/jats:p>","DOI":"10.1592\/phco.25.1.59.55627","type":"journal-article","created":{"date-parts":[[2004,12,16]],"date-time":"2004-12-16T10:27:43Z","timestamp":1103192863000},"page":"59-66","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Blood Culture and Susceptibility Results and Allergy History Do Not Influence Fluoroquinolone Use in the Treatment of Community\u2010Acquired Pneumonia"],"prefix":"10.1002","volume":"25","author":[{"given":"Nancy N.","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia K.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter M.","family":"Houck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dale W.","family":"Bratzler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudette","family":"Greenway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. Joseph","family":"Guglielmo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,1,16]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.10.1399"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1086\/380488"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1086\/313959"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.163.7.at1010"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-129-11_Part_1-199812010-00015"},{"key":"e_1_2_1_7_2","unstructured":"Intraagency Task Force on Antimicrobial Resistance Co\u2010chairs: Centers for Disease Control and Prevention Food and Drug Administration National Institutes of Health Agency for Healthcare Research and Quality Health Care Financing Administration Health Resources and Services Administration Department of Agriculture Department of Defense Department of Veterans Affairs Environmental Protection Agency.A public health action plan to combat antimicrobial resistance 2001. Available fromhttp:www.cdc.govdrugresistanceactionplanhtmlindex.htm. AccessedDecember 1 2003."},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1086\/344768"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-198812000-00005"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.108.4.932"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.116.5.1278"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1053\/rmed.2000.0977"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.121.5.1486"},{"key":"e_1_2_1_14_2","first-page":"800","article-title":"Resistance of Streptococcus pneumoniae to fluoroquinolones: Unites States, 1995\u20131999","volume":"50","author":"Centers for Disease Control and Prevention.","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199907223410403"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1086\/322658"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0806.010275"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1086\/374052"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200012283432603"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1086\/376642"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012122"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.22.5.395.33185"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkf808"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.7.885"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0732-8893(01)00254-1"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(01)00317-X"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.5.1681-1688.2003"},{"key":"e_1_2_1_28_2","first-page":"321","volume-title":"Community fluoroquinolone (FQ) use and its relationship to hospital rates of ciprofloxacin\u2010resistant Pseudomonas aeruginosa (CRPa): a SCOPE\u2010MMIT report [abstr]","author":"Johnson CK","year":"2002"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1086\/341771"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1592%2Fphco.25.1.59.55627","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1592\/phco.25.1.59.55627","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:16:52Z","timestamp":1761045412000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1592\/phco.25.1.59.55627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["10.1592\/phco.25.1.59.55627"],"URL":"https:\/\/doi.org\/10.1592\/phco.25.1.59.55627","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"type":"print","value":"0277-0008"},{"type":"electronic","value":"1875-9114"}],"subject":[],"published":{"date-parts":[[2005,1]]},"assertion":[{"value":"2012-01-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}